Pedro Rosa Neto, MD. M.Sc, Ph.D.
iCurriculum Vitae
6 February 2016
A. Identification
Name
Pedro Rosa-Neto
Office Address:
Alzheimer’s Disease Research Unit
Translational Neuroimaging Laboratory
McGill Centre for Studies in Aging
Douglas Hospital Research Center
McGill University
6875 LaSalle Blvd, FBC #1144, F-0105
Montréal, QC, Canada H4H 1R3
tel: 514-761-6131 ext 3446
url
http://alzheimer.mcgill.ca/index.html
http://tnl.research.mcgill.ca/
http://aging.mcgill.ca/
Curriculum Vitae
E-mail
pedro.rosa@mcgill.ca
pedro.rosa@alzheimer.mcgill.ca
pedro@bic.mni.mcgill.ca
Citizenship
Canadian (Permanent Resident)
Brazilian
Languages
Portuguese, English, French
h-index (2010-15)
I10-index (2010-15)
22
38
Signature
_________________________________
Key words
Clinical neurology, Dementia, Alzheimer’s
disease, translational neurology, integrative
neuroimaging, PET, MRI, Clinical trials.
1
Pedro Rosa Neto, MD. M.Sc, Ph.D.
B. Education
2008
PDF (MRI) – MNI – Supervisor: Allan Evans
2005
PhD (PET) Aarhus University, Aarhus,
Denmark. Supervisor: Albert Gjedde Paul
Cumming
2005
Fellowship (PET) MNI Supervisor: Mirko
Diksic and Chawki Benkelfat
1999
M.Sc. (Neurochemistry): Brazilian Ministry
of Education and Culture, Federal
University of Rio Grande do Sul,
Department of Biochemistry Porto Alegre,
RS, Brazil Carlos Alexandre Netto
1994
Specialist in Neurology. Brazilian Ministry
of Education and Culture and St Lucas
University Hospital, Pontifical University of
Rio Grande do Sul, Porto Alegre, RS,
Brazil.
1990
MD. Ministry of Education and Culture,
Federal University of Rio Grande do Sul,
Faculty of Medicine, Porto Alegre,
RS,Brazil. (This Medical diploma received
the equivalence by The University of
Lisboa, Portugal, in October 2003
Canada
Physician: Order of Physicians of Quebec
Professional Affiliations
Medical Council of Canada: approved in the
Evaluating Exam (November, 2004).
Collège de Medecins du Quebec Permit #
10627
Portugal
Medical diploma re-issued by The
University of Lisboa (2003), Portugal. MD
licence (#45-574) issued by the Order of
Physicians of Portugal.
Brazil
Certified Neurologist by the Brazilian
Ministry of Education and Culture (1994).
MD license issued by the Regional Council
of Medicine of Rio Grande do Sul (1990),
Federal Republic of Brazil number 17899.
Curriculum Vitae
2
Pedro Rosa Neto, MD. M.Sc, Ph.D.
C. Appointments
Neurologist
Alzheimer’s Disease Research Unit McGill Centre for
Studies in Aging (ADRU)
Neurologist and deputy director of the
The PREVENT-Alzheimer Program (StoP-AD)
Associate Professor – Clinical Scientist
Departments of Neurology & Neurosurgery and Psychiatry
Affiliated Researcher
http://www.bic.mni.mcgill.ca/PeopleAffiliates/RosaNetoPedro
Professeur associé Département de psychologie
UQAM - Université du Québec à Montréal
http://www.psychologie.uqam.ca/departement/corpsprofessoral/par-section/26-pedro-rosa-neto.html
Associate Leader
CIHR Canadian Consortium on Neurodegeneration in Aging
(CCNA) for Team #2 “ Inflammation and Trophic Factor
Deregulation in Alzheimer’s disease”
Chair and National Coordinator
Functional neuroimaging and PET
CIHR Canadian Consortium on Neurodegeneration in Aging
(CCNA)
Positions held
Curriculum Vitae
2004-2007
International Consortium for Brain Mapping
(ICBM) post-doctoral fellow at McConnell
Brain Imaging Centre, Montreal
Neurological Institute and Hospital,
Montreal, QC, Canada. Supervision - Alan
C Evans.
2003-2004
Ph.D. student, Aarhus University, Aarhus,
Denmark
2002-2003
Klinisk Adjunct at PET Centre, Aarhus
University Hospital, Aarhus Denmark.
2001-2002
Klinisk assistant (Dr. Albert Gjedde) at the
PET centre Aarhus Kommune Hospital
1998-2001
Fellow at the McConnell Brain Imaging
Centre, Montreal Neurological Institute and
Hospital, Montreal, QC, Canada
3
Pedro Rosa Neto, MD. M.Sc, Ph.D.
1996-1997
Consultant Neurologist at the Dong KwangJu General Hospital Epilepsy Program,
Kwangju, South Korea.
1994-1996
Neurologist at the Neuropsychiatry and
Behavioural Neurology Clinic of the
Department of Psychiatry at the Federal
Foundation of Medicine, Porto Alegre, RS,
Brazil.
1994-1996
Neurologist at the President Vargas
Hospital, Porto Alegre, RS, Brazil and at the
Department of Psychiatry at the Federal
Foundation of Medicine, Porto Alegre, RS,
Brazil.
1994-1995
Electroencephalographer (junior) at the
President Vargas Hospital, Porto Alegre,
RS, Brazil.
1994-1995
Electroencephalographer (junior) at the
Neurolab, Mae de Deus Hospital, Porto
Alegre RS, Brazil.
1992-1993
Resident in Neurology at St Lucas Hospital,
Pontifical University of Rio Grande do Sul,
Porto Alegre, RS, Brazil (two years).
1991-1992
Resident in Internal Medicine at St Lucas
Hospital, Pontifical University of Rio Grande
do Sul, Porto Alegre, RS, Brazil (one year).
D. Honors
2009-2010
2012-2013
Alzheimer’s Disease New
investigator Award – Alzheimer’s
Association, USA.
Alzheimer’s Disease New
investigator Award – Alzheimer’s
Association, USA.
E. Teaching
1. McGill Courses
Curriculum Vitae
2014
Training program for research on
lumbar puncture technique using the
atraumatic 24G sprotte needle at
StoP-AD Centre (Chief of Training
Program).
2013
Resident teaching day on imaging
and dementia.
2013
Resident teaching day on imaging
4
Pedro Rosa Neto, MD. M.Sc, Ph.D.
and dementia.
Course “Topics in radionuclide
imaging: from Bench to Bedside
2009” NEURO607 (6h / y)
2009-2013
2. Research Trainees Supervised
Curriculum Vitae
2015-
Co-supervision of fellow Natalia Del
Campo. Project: Regional effects of
amyloid in Alzheimer’s disease.
2015-2015
Supervision of visiting scholar Roberto
Wajman MD.
2014-2015
Co-supervision of fellow Paolo Vitali MD.
Project: Identification in vivo des depots
toxiques de la protein tau dans le cerveau
de patients avec une tauopathie: une etude
pilote par tomographie par emission de
positons.
2014-2016
Supervision of MSc student Ishan Walpola
BSc. Project: Neuroimaging of mindfulness
meditation in aging Alzheimer’s disease.
2014-2015
Supervision of undergraduate student Ryan
Monsberger. Project: Changes within
motor cortex functional connectivity: a
possible compensatory mechanism
underlying motor deficits in AD.
2014-2015
Supervision of undergraduate student
Laura McDougall. Project:
2011-2014
Supervision of fellow Laksanun
Cheewakreingkrai MD. Project: Imaging
biomarkers of dementia.
2013-2014
Supervision of fellow Sarinporn
Manitsirikul MD. Project: Imaging
biomarkers of dementia.
2014-2019
Supervision of fellow and PhD student
Tharick Ali Pascoal MD. Project: Imaging
biomarkers of dementia.
2012-2012
Co-supervision of fellow Thiago
Hartzmann FFCMPA. Project: Cingulate
gyrus segmentation.
2011-2013
Supervision of fellow Marina Dauar MD.
Project: Memory systems affected in AD.
2010-2011
Supervision of fellow Liyong Wu MD, PhD.
Project: Imaging biomarkers on dementia.
5
Pedro Rosa Neto, MD. M.Sc, Ph.D.
Curriculum Vitae
2010-2015
Supervision of PhD student Maxime Parent
MSc. Project: Imaging [18F]FEOBV.
2013-2014
Supervision of PhD student Eduardo
Rigon Zimmer MSc. Project: Imaging
mGLUR5 in AD.
2013-2016
Supervision of PhD student Andréa Lessa
Benedet MSc. Project: Genotype – imaging
endophenotype correlations in AD.
2013-2013
Supervision of PhD student Lucas
Schilling MD. Project: Imaging White
matter neurodegeneration with PET.
2013-2015
Supervision of MSc student Monica Shin.
Project: Imaging neurodegeneration with
MRI in AD TG rat Model.
2013-2015
Supervision of MSc student Seqian Wang.
Project: Imaging neurodegeneration with
rsfMRI.
2013-2017
Supervision of MSc student Min Su Peter
Kang. Project: Imaging neuroinflammation
with PET in AD model.
2013-2016
Supervision of MSc student Sulantha
Matotaarachchi. Project: Imaging
neurodegeneration with integrative
neuroimaging methods.
2012-2014
Supervision of MSc student Antoine Leuzy
BSc. Project: mGLUR5 alterations in FTD
2010-2011
Supervision of fellow Ricardo Bernadi
Soder PhD. Project: resting State fMRI in
AD.
Sep 2009-Oct
2009
Supervision of MSc student Betteke van
Noort, BSc (internship/thesis for the
Research Master Neuropsychology at
Maastricht University, The Netherlands), in
co-supervision with Prof. Dr. Wim Riedel
(Maastricht University). Project: mGLUR5
and glucose metabolism changes in AD
patients, with use of PET tracers FDG and
[11C]ABP688.
Sep 2009-Oct
2009
Supervision of summer Post-Doctoral
Fellow student Dr. Marina Teseschi Dauar
MD. Project: Glutamatergic
neurotransmission on AD.
2010-2013
Supervision of undergraduate student Sara
Mohades. Project: Structural deficits in AD.
6
Pedro Rosa Neto, MD. M.Sc, Ph.D.
2009-2010
Supervision of undergraduate Student
Dorothee Schoemaker. mGLUR5
changes in the inferior parietal cortex of AD
patients.
2009-2009
Co-supervision of PhD student Evelyne
Landry St. Pierre. Project: FEOBV
radiometabolites.
2008-2011
Supervision of MSc student Jared Rowley.
Project: Probabilistic Fiber tracking in AD.
2008-2009
Supervision of Visiting Scientist (fellow) Dr.
David Elmenhost MD. Project:
Glutamatergic abnormalities in animal
model of epilepsy using microPET.
2008-2011
Supervision of McGill University Post
Doctoral Fellow Dr. Luciano Minuzi MD,
PhD. Project: Quantification of
glutamatergic abnormalities in AD using
PET
MSc .
external
examiner
2011
Sarah Grant (PI, Alexander Thiel)
MSc.
advisory
committee
member
2011
Dafneé Lalonde (PI, Judes Poirrier)
PhD
advisory
committee
member
2011
John Chen (PI, Alan Evans)
PhD
advisory
committee
member
2013
Mahsa Dadar (PI, Louis Collins)
PhD
advisory
committee
member
2013
Louisa Dahmani (PI, Veronique Bobot)
Advisory
committee
2014
Lindsay Wallace (PI, Natasha Raja)
Advisory
committee
2014
Luisa Sa Barreto Pimentel (PI, Claudio
Cuello)
External
examiner
Curriculum Vitae
7
Pedro Rosa Neto, MD. M.Sc, Ph.D.
Advisory
committee
2012
Jonathan DuBois (PI, Eliane Kobayashi)
1. Clinical Rounds
2013-present
Twice per month at Moe Levin Unit
Target population: Psychiatry
residents and fellows
2014 -present
Training on CSF sampling for
research and clinical applications
Target population: clinical fellows
F. Other Contributi ons
Review Panels
1. Journal Ad Hoc reviewer
Curriculum Vitae
2001- today
Reviewer for the Journal Biological
Psychiatry
2001- today
Reviewer for the Journal Lancet Neurology
2001- today
Reviewer for the Journal American Journal
of Psychiatry
2001- today
Reviewer for the Journal Parkinsonism &
Related Disorders
2001- today
Reviewer for the Journal Archives of
General Psychiatry
2001- today
Reviewer for the Journal Synapse
2001- today
Reviewer for the Canadian Journal of
Neurological Sciences
2001- today
Reviewer for the Journal
Psychopharmacology
2001- today
Reviewer for the Journal Neuroimage
8
Pedro Rosa Neto, MD. M.Sc, Ph.D.
2001- today
Reviewer for the Journal Brain Connectivity
2001- today
Reviewer for the Canadian Journal of
Neurological Science
Scientific
Reports
http://www.grsnc.umontreal.ca/pub/rapports
/GRSNC_rapport_2004-2005.pdf
2. Panel Member
Provincial Review Boards
2012-2014
FQR Commite d’evaluation des demandes
de bourses de formation de maîtrise
permanent
member
National Review Boards (Ad Hoc Member)
2012-2014
CIHR PhD Awards committee
AD hoc
2011-2012
2011-2012 Peer Review Committee –
Doctoral Research Awards A (DRA201110)
http://www.cihr-irsc.gc.ca/e/45367.html
International Review Boards (Ad Hoc Member)
2007
Reviewer for the NIH / NIMH Silvio O.
Conte Center (Ad-hoc - imaging)
2008
Reviewer for the NIH / The Biobehavioral
Regulation, Learning and Ethology [BRLE]
Study Section (Ad-Hoc - imaging)
2009
Reviewer for the NIH / The Biobehavioral
Regulation, Learning and Ethology [BRLE]
Study Section (Ad-Hoc - imaging)
http://www.csr.nih.gov/Roster_proto/meetin
g_roster_print.asp?srg=BRLE&SRGDISPL
AY=BRLE&agsqnum=200002&grcode=&st
date=6/12/2008&enddate=6/13/2008
Curriculum Vitae
2010
Reviewer for the The Netherlands
Organization for Health Research and
Development (zonWm)
2013
Reviewer for the Research Foundation
Flanders (FWO)
2013
Reviewer for the agence-nationalerecherche, France.
9
Pedro Rosa Neto, MD. M.Sc, Ph.D.
MRC – Great Brittain Peer Review Request
3. Administrative Responsibilities
2013
McGill Centre for Studies in Aging Board of
Directors member 1h/w
4. Intramural Committees
2012-
Member of the Douglas Research Centre
Brain Imaging Centre Executive Committee
10 h /y.
2004-
Member of the Montreal Neurological
Institute PET business committee
2011-
Member of the Douglas Hospital Ethics
Committee (Imaging Consultant) 22 h /y
2010-
Member of the MNI small Imaging Ethics
Committee
2011-
Member of the MNI MEG Research
Committee Meeting (Imaging Consultant) 5
h /y
5. Professional and/or Learned Societies
2012-2013
American Academy of Neurology (member)
2012-2013
European College of
Neuropsychopharmacology (member)
2012-2013
Alzheimer’s Association (member)
6. Industry Sponsored Clinical Trials
Curriculum Vitae
Role
Duration
Name
PI
2015-2017
A Phase 3 Clinical Trial to Evaluate the
Efficacy and Safety of [18F]NAV4694 PET
for Detection of Cerebral β-Amyloid When
Compared With Postmortem
Histopathology (NAV4-02) Sponsor:
Navidea.
10
Pedro Rosa Neto, MD. M.Sc, Ph.D.
Curriculum Vitae
PI
2013-2015
A Double-Blind, Placebo-Controlled,
Randomized, Parallel Group, 12-Month
Safety and Efficacy Trial of Leucomethylthioninium bis
(hydromethanesulfonate) in Subjects with
Behavioral Variant Frontotemporal
Dementia (bvFTD) (Protocol number TRx237-007). Sponsor: TauRx
Sub-I
2013-2015
A phase III randomized, placebo-controlled,
parallel-group, double blind clinical trial to
study the efficacy and safety of MK-8931
(SCH 900931) in subjects with amnestic
mild cognitive impairment due to
Alzheimer’s Disease (prodromal AD)
(Protocol MK-8931 019). Sponsor: Merck
Sub-I
2013
Long-Term Safety and Tolerability of ABT126 in Subjects with Mild‑ to-Moderate
Alzheimer's Disease on Stable Doses of
Acetylcholinesterase Inhibitors: An OpenLabel Extension Study for Subjects
Completing Study M11-793 (Protocol
number M11-428) Sponsor: AbbVie,
Canada
Sub-I
2012-2013
A randomized, double-blind, placebocontrolled study to evaluate the efficacy and
safety of ABT-126 in subjects with mild-tomoderate Alzheimer’s disease on stable
doses of acetylcholinesterase inhibitors
(Protocol M11-793). Sponsor: AbbVie,
Canada
PI
2011-2012
A multinational, multicenter, randomized,
double-blind, parallel-group, placebocontrolled study of the effect on cognitive
performance, safety, and tolerability of
AR110894D at the doses of 0.5 mg, 2 mg,
and 5 mg/day for 24 weeks in patientswith
mild to moderate Alzheimer's Disease on
stable donepezil therapy (Protocol
SAR110894D - DRI10734). Sponsor:
Sanofi, Canada“
PI
2012-2013
A Study to Assess the Feasibility,
Sensitivity and Specificity of CSF Collection
for Assays of Alzheimer's Disease
Biomarkers (Protocol 0000-261-00).
Sponsor: Merck,Canada
Sub-I
2012-2015
Pre-symptomatic evaluation of experimental
or novel treatments for Alzheimer’s disease
(prevent-ad) collection of cerebrospinal fluid
(csf) for outcomes in the prevent-ad
program. CIHR
11
Pedro Rosa Neto, MD. M.Sc, Ph.D.
Sub-I
2011-2013
Substudy In Association With Mabt5102a Study ABE4869g Sponsor: Genentech
G. Research Grants
Curriculum Vitae
2015-2019
Non-invasive Identification of Aβ
Plaques in Human Retina for the
Diagnosis of Alzheimer’s Disease.
Brain Canada CQDM Focus on the
Brain (CAN$ 1,500,000). Soucy,
Jean-Paul; Lesage, Frederic; Black,
Sandra; Sylvestre, Jean-Philippe;
Arbour, Jean Daniel; Rosa-Neto, P;
Greenberg, Barry; Hudson, Chris;
Farkas, Daniel.
2015-2019
Integrated Platform for Imaging and
Drug Delivery across the Human
Blood-Brain Barrier. Brain Canada
CQDM Focus on the Brain (CAN$
149,300). Yoganathan, Nathan;
Collins, Louis; Stanimirovic, Danica;
Chakravarthy, Balu; Soucy, JeanPaul; Rosa-Neto, Pedro.
2014-2018
Microglial Activation in Alzheimer’s
Disease. CIHR - The Canadian
Consortium
on
Neurodegeneration in Aging,
CCNA. (CAN$ 50,000).
RosaNeto, Pedro. Sole applicant.
2014-2015
Molson’s KT grant in Aging
Research (CAN$25,000). Advances
in FTD. Rosa-Neto, Pedro (PI);
Gauthier, Serge; Pruessner, Jens,
Leuzy, Antoine.
2013-2015
Combination of structural and
functional
brain
magnetic
resonance
imaging
for
the
diagnosis of AD in the prodromal
stage. Vieillissement CIHR (CAN$
50,000).
Bellec,
Pierre
(PI);
Belleville, Sylvie Ninon; Collins, D.
Louis; Rosa-Neto, Pedro.
2014-2018
FRSQ Programme de bourses de
chercheur-boursier «Junior 2»
Volet « Clinique et Épidémiologie »
FRSQ (CAN$ 271.439)
12
Pedro Rosa Neto, MD. M.Sc, Ph.D.
2013-2013
Validation
du
18FFluoroethoxybenzovesamicol
(FEOBV) comme biomarqueur de
la maladie d'Alzheimer. Programme
de
subvention
–
Fond
d’innovation Pfizer-FRQS sur la
maladie
d’Alzheimer
et
les
maladies apparentées – Volet 2.
Cuello, Claudio (PI); Kriz, Jasna;
Rosa-Neto, Pedro.
2013-2015
Nouveaux outils non-invasifs pour
la détection précoce de la
pathologie de la maladie
d'Alzheimer. Programme de
subvention – Fond d’innovation
Pfizer-FRQS sur la maladie
d’Alzheimer et les maladies
apparentées – Volet 2 (CAN$
200,000). Bedard, Marc-André (PI);
Rosa-Neto, Pedro; Soucy, JeanPaul.
2013-2017
Diagnostic Biomarkers for predementia Alzheimer Disease.
CIHR team grant (CAN$
1,000,000). Gauthier, Serge (PI);
Jia, Jianping (PI); Doudet, Doris J;
Hsiung, Ging-Yuek R; Labbe,
Aurelie; Rosa-Neto, Pedro;
Sadovnick, A. Dessa.
http://webapps.cihrirsc.gc.ca/cfdd/db_search?p_language=E&p
_competition=201206TAD
Curriculum Vitae
2013-2014
Refining
functional impairment
criteria in individuals diagnosed
with Mild Cognitive Impairment.
Richard and Edith Strauss
Canadian Foundation
(CAN$
12,000). Belchior, Patricia (PI);
Gelinas, Isabelle; Wai, Jade.
2013-2014
In vivo quantification of biomarker
progression on the APP-RAT
model. Alzheimer’s Association
New Investigator Award (CAN$
100,000). Rosa-Neto, Pedro. Sole
applicant.
2013-2014
Molson’s KT grant in Aging
Research
(CAN$
25,000.00).
Advances in Alzheimer’s disease.
Rosa-Neto, Pedro (PI); Gauthier,
Serge; Pruessner, Jens; Leuzy,
Antoine.
13
Pedro Rosa Neto, MD. M.Sc, Ph.D.
2012-2016
Le Centre d'Imagerie Cérébrale de
l'Institut Douglas au service de la
santé mentale: développement
d'une plateforme de recherche
translationelle pour la prévention, le
rétablissement et l'innovation.
FRSQ Budget développement
recrutement. (CAN$ 1,400,000).
Rajah, Maria Natasha (PI); Gratton,
Allain (PI); Giros, Bruno; Walker,
Dominique;
Turecki,
Gustavo;
Pruessner, Jens; Adamantidis,
Antoine; Meaney, Michael.
2012-2015
Genetic and Biomarker Profile of
Early Onset Familial Alzheimer’s
Disease. CIHR- Team Grant
(China-Canada:
Alzheimer’s
Disease and Relations). (CAN$
1,000,000). Gauthier, Serge (PI);
Sadnovinik, Dessa; Doudet, Doris;
Rosa-Neto, Pedro.
2011-2015
Glutamatergic abnormalities of AD.
CIHR (CAN$ 650,000) Rosa-Neto,
Pedro (PI); Gauthier, Serge; Soucy,
Jean-Paul.
http://webapps.cihrirsc.gc.ca/funding/detail_
e?pResearchId=2724006&p_version=CIHR
&p_language=E&p_session_id=1125742
2011
Glutamatergic abnormalities of AD.
CIHR (CAN$ 30,000) Rosa-Neto,
Pedro (PI); Gauthier, Serge; Soucy,
Jean-Paul.
McGill University Bridge Fund
2011-2012
Platform
for
fluid
biomarker
research in dementia. MNI Centre
of
Excellence
in
Commercialization and Research
(CAN$ 50,000). Rosa-Neto, Pedro.
Sole applicant.
2011-2012
In vivo investigations of brain
dopaminergic plasticity in humans.
CIHR (CAN$ 3,280,000). Benkelfat,
Chawki; Dagher, Alain; Leyton,
Marco Arnold; Douglas, Lorne;
Narayan, Sridar; Rosa-Neto, Pedro.
http://webapps.cihrirsc.gc.ca/funding/detail_e?pResearchId=27
14747&p_version=CIHR&p_language=E&p_
session_id=1125742
2010-2011
Curriculum Vitae
Anatomo behavioral validation of
14
Pedro Rosa Neto, MD. M.Sc, Ph.D.
the
[18F]fluoroethoxybenzo
vesamicol, as a PET radiotracer for
the diagnosis of Alzheimer disease.
CIHR (CAN$50,000). Bedard, MA;
Soucy, Jean-Paul.
http://webapps.cihrirsc.gc.ca/funding/detail_e?pResearchId=27
23849&p_version=CIHR&p_language=E&p_
session_id=1125742
2009
Development of an automated
blood counter for quantitative
molecular imaging applications.
NSERC (CAN$ 282,405). Després,
Philippe (PI); Soucy, Jean-Paul;
Rosa Neto, Pedro; Hamel, LouisAndré.
http://www.nserccrsng.gc.ca/NSERCCRSN
G/FundingDecisionsDecisionsFinancement/CHRPPRCS/index_e
ng.asp?Year=2010
2009-2015
Laboratoire
de
Neuroimagerie
Integrative pour la Recherche
Moleculaire Translationelle dans la
Demence. Canada Foundation for
Innovation (CFI) (CAN$ 350,000).
Rosa-Neto, Pedro. Sole applicant.
2009-2013
FRSQ Programme de bourses de
chercheur-boursier «Junior 1» Volet
« Clinique et Épidémiologie »
(CAN$ 423,927) Sole applicant.
2008-2009
Integrative
Neuroimaging
Laboratory
for
Translational
Molecular Research in Dementia.
Canada
Foundation
for
Innovation. (CAN$ 330,000) –
Sole applicant
2009-20011
Glutamatergic Abnormalities in
Patients with Early Alzheimer's
Disease. Alzheimers Association,
New Investigator Award (US$
100,000) – Sole applicant
http://www.alz.org/research/alzheimers_gran
ts/for_researchers/overview2008.asp?grants=2008rosaneto
2009-2015
Multi-parametric imaging studies of
novel therapeutic agents in rodent
models of glioma. CIHR (CAN$
300,000; 4 years). Bedell, Barry J.
(PI); Stanimirovic, Danica; Evans,
Allen C.; Pike, Bruce.
http://webapps.cihrirsc.gc.ca/funding/detail_e?pResearchId=27
27188&p_version=CIHR&p_language=E&p_
Curriculum Vitae
15
Pedro Rosa Neto, MD. M.Sc, Ph.D.
session_id=1125742
2003-2009
The
[18F]
FluoroEthoxybenzovesamicol for PET
imaging: A tool for the diagnosis
and the study of neuroprotection in
Alzheimer’s disease. Pfizer Inc
(US$ 100,000). Soucy, Jean-Paul;
(PI), Rosa-Neto, Pedro; Mzengesa
Shadreck; Bédard, Marc-Andre.
2008-2009
A new radioligand for monitoring of
Alzheimer's patients. Centres of
Excellence for
Commercialization and Research
(CAN$ 100,000). Diksic, Mirko (PI);
Massarweh, Gassan; Rosa-Neto,
Pedro.
2008-2009
PIA-ARACHNOID-Platform
for
Integrated,
Advanced
Animal
Research for Complex Human
Neurological,
Oncological
and
Inflammatory Diseases. Centres of
Excellence
for
Commercialization and Research
(CAN$ 100,000). Beddel, Barry J.;
Nalbantoglu, J. Hammel, E; RosaNeto, Pedro.
2003-2004
Co-applicant of the project “Effects
of
heterogeneous
sensation
seeking
on
dopaminergic
neurotransmission
and
energy
metabolism
in
pathological
gamblers”.
Danish
Medical
Research Council (€ 606.252,00).
Linnet Jakob (PI); Gjedde, Albert;
Cumming,
Paul;
Roepstorff,
Andreas; Rosa-Neto, Pedro; Jørsel
Michael; Nygaard, J; Bechara,
Antoine.
Pri vate Consultant Acti vities
Curriculum Vitae
2013
Consultant in Positron Emission
Tomography research methodology for the
company Pfizer - Canada.
2013
Consultant in Positron Emission
Tomography research methodology for the
company Novartis - Canada
2013
Consultant in Positron Emission
Tomography research methodology for the
16
Pedro Rosa Neto, MD. M.Sc, Ph.D.
company Pyramal - USA
2013
Consultant in Positron Emission
Tomography research methodology for the
company General Electric - USA
2007-2009
Consultant in Positron Emission
Tomography research methodology for the
company Biospective Inc - Canada.
Academic Consultant Acti vities
2010-2011
2010-2011
Consultant
in
Positron
Emission
Tomography research methodology for the
Brain Institute – Pontifical University of Rio
Grande do Sul, Brazil.
Workshop sponsor by German Centre for
Neurodegenerative Diseases (DZNE), The
UK Medical Research Council (MRC) and
the Canadian Institute of Health research
(CIHR) "Standard Operating Procedures
and Biomarkers in neurodegenerative
diseases" held in Bonn on December 1314,
2010.
http://www.coen.org/uploads/media/Workshop_SOP_B
ooklet_2010_Bonn.pdf
Academic teaching acti vities
Mentorship Experience : see teaching
Invited talks
Venue
Curriculum Vitae
Title
Western University, Neurology Rounds,
20 November 2014. London, Ontario,
Canada.
Translational
Neuroimaging in
Alzheimer’s Disease
Fuku University, Neurological Talks. 10
November 2014, Fukushima, Japan
Translational
Neuroimaging in
Alzheimer’s Disease
Tel-Aviv University, Quebec-Israeli
Symposium on Biomedical Imaging 27-28
May 2014, Beit Hatfutsot, Tel Aviv
PET imaging interfacing
animal models and
human Alzheimer’s
disease.
University of Laval: Symposium Sur
L’imagerie Des Démences 23 mai 2014,
Differential Diagnosis of
dementias
17
Pedro Rosa Neto, MD. M.Sc, Ph.D.
8h-12h. L’imagerie cérébrale au service
du diagnostic différentiel des démences
University of Manitoba Symposium:
Small Animal Imaging: Advances and
Applications. Winnipeg, 30 Sep, 2013.
From microPET to
clinical PET:
Translational imaging
biomarker research in
Alzheimer's disease
Canadian Academy of Geriatric
Society: 25Sep 2013, Ottawa Convention
Centre.
The Role of Imaging in
Cognitive Disorders, A
review from the fourth
Canadian Consensus
Conference of Diagnosis
and treatment of
dementia (CCCCDT-4)
http://www.cagp.ca/Default.aspx?pageId=1583427
Gwangju Institute of Technology South
Korea. http://neuro.gist.ac.kr/
March 3, 2013
Translational research in
Alzheimer’s disease.
Canadian Association of Nuclear
Medicine Meeting, Session on amyloid
imaging Amyloid imaging Québec City,
QC, January 24, 2013
Advances on Amyloid
Imaging
Colloque "Vieillir au XXIe siècle :
approches préventives, diagnostiques
et restauratives" 30e anniversaire du
Centre de recherche de l'Institut
universitaire de gériatrie de Montréal
Montreal, 11-12 October, 2012.
http://criugm.qc.ca/vieillir21e/
Quantifying amyloid
pathology and
neurodegeneration in
AD: an imaging
biomaker perspective.
Continuing Education Course on
Functional Neuroimaging: A Hands-On
Approach. Georgetown University,
Washington D.C. and Brain Institute
(Instituto do Cérebro-InsCer) at PUCRS,
Porto Alegre, Brazil June 27-29, 2012
http://www3.pucrs.br/portal/page/portal/ed
ucon/index/extensao/curso?cd_curso=468
What is Positron
Emission Tomography
The fourth Canadian Consensus
Conference on the Diagnosis and
Treatment of Dementia (CCCDTD4)
Montreal, May 4th and 5th, 2012.
Consensus on Fluid
Biomarkers
Symposium in Radiopharmacy and
molecular imaging. Porto Alegre Brazil –
25-28 Aug 2011
Molecular Imaging in
Dementia
Neurosciences Seminar.
CIMA - Navarra University
Pamplona. 13-September-2010
Imaging plasticity in
patients with mild
cognitive impairment.
Research applications of
PET
http://www.cima.es/agenda/mes/10/2010
Curriculum Vitae
18
Pedro Rosa Neto, MD. M.Sc, Ph.D.
International conference on brain
function and development.
University of Fukui – Japan 25-26. 2010.
In vivo imaging of
metabotropic glutamate
dysfunction in
neurological diseases.
Self: Mind and Brain Symposium at
Arhus university Hospitals 26 jan2009
Imaging glutamate
receptors: the link
between
neurotransmission and
brain function
Opening Lecture at the Porto Alegre
Brain Institute
Porto Alegre - December 20Dec2008
Molecular imaging by
PET
http://www3.pucrs.br/portal/page/portal/pucrs/Ca
pa/Noticias?p_itemid=1249468
Canadian Academy of Child and
Adolescent Psychiaytry 27th Annual
Conference. Symposium “Neuroimaging
in child psychiatry” 2007
PET and SPECT
research in child
psychiatry
Danish Parkinson’s Disease Society, Dr
H. Pakkenberg’s Lecture, Aarhus, May
2004
PET outcome measures
as biomarkers of
Parkinson’s Disease
Honam Epilepsy Society, Gwangju,
Korea, January 1997
Clinical aspects of
Mesial Lobe Epilepsy
Syndrome
Scientific Committees
Curriculum Vitae
2007
European College of
Neuropsychopharmacology
20 ECNP meeting, Viena
2007. Chairman of the
brainstorming section
“Translational
Neuroimaging”
2011
Quebec Network for memory
Clinic
2011“ Chair of scientific
Committee”
2012
Member of Canadian
Consensus on Dementia
2012: executive committee,
“Chair on Fluid Biomarkers”
2014
Associate Leader of the
CIHR Canadian Consortium
on Neurodegeneration in
Aging (CCNA) for Team #2
focused on “ Inflammation
and Trophic Factor
Deregulation in Alzheimer’s
disease”
“Associate Leader”
2015
Chair and National
Coordinator of the CIHR
“Chair and National
19
Pedro Rosa Neto, MD. M.Sc, Ph.D.
Canadian Consortium on
Neurodegeneration in Aging
(CCNA) focused on
“Functional Neuroimaging
and PET”
Coordinator”
Memberships
Honam Epilepsy Society
Brazilian Society of Neuroscience and
behavior
Brazilian League against Epilepsy
New York Academy of Sciences
Society for Neuroscience
European College of
Neuropsychopharmacology
Academy of Molecular Imaging
American Academy of Neurology
Theses
PhD thesis.
Aarhus
University,
Denmark
(2005)
Activation of striatal dopamine receptors by
psychostimulants: receptor anatomy,
autonomic and behavioral effects.
MSc thesis.
Federal
University of
Rio Grande do
Sul (1999).
The time course of the enzyme cytochrome
oxidase and glycogen phosphorylase in the
rat hippocampus submitted to transient
ischemia: the effect of ischemic tolerance.
Editorial Acti vities
Curriculum Vitae
Editor
Book: “Case studies in dementia”. Cambridge Press,
Cambridge, UK.
Editor
Book: ““Advances in Alzheimer's Disease Management”,
Gauthier, S. and Rosa-Neto, P. Future Medicine, London,
UK ICBN 978-1-78084-0857 http://www.futuremedicine.com/doi/book/10.2217/9781780
20
Pedro Rosa Neto, MD. M.Sc, Ph.D.
840840
Co-editor
Periodical: “Alzheimer’s Rounds”. Alzheimer’s Society
SNELL Medical Communication Inc
http://www.alzheimerrounds.ca/cgibin/templates/body/accueil.cfm
Assistant
editor
The Journal of Alzheimer's Disease
http://www.j-alz.com/board
Book chapters / Proceedings
1. Le diagnostic précoce de la maladied’Alzheimer : panacée ou catastrophe? Dr S.
Gauthiera, B. Dubois, J. Poirier, A. Leuzya, P. Rosa-Neto. Ethics, Medicine and Public
Health (2015) 1, 151—154
2. Diagnosis of Alzheimer’s disease by Pedro Rosa-Neto, Jared Rowley, Antoine Leuzy,
Sara Mohades, Monica Shin, Marina T Dauar and Serge Gauthier. In “Advances in
Alzheimer's Disease Management”, Gauthier, S. and Rosa-Neto, P. Future Medicine,
London, UK.
3. Case of a young man smoking pot but with a mother who died of dementia. Gauthier, S.,
Rosa-Neto, P., Soucy, J-P. Leonard, G. In “Case studies in Dementia”, Gauthier, S. &
Rosa-Neto, P. Cambridge University Press. Cambridge, UK.
http://ebooks.cambridge.org/ebook.jsf?bid=CBO9780511997433
4. Young man with slow cognitive decline. Guiot, M.C. Rosa-Neto, P. In “Case studies in
Dementia”, Gauthier, S. & Rosa-Neto, P. Cambridge University Press. Cambridge, UK.
5. Verhaeghe, J. , Gravel, P., Mio, R., Fukasawa, R, Rosa-Neto, P., Soucy, J-P.,
Thompson CH., and Reader AJ. Motion-Compensated Fully 4D PET Reconstruction using
PET Data Supersets @ 2009 IEEE MIC meeting.
6. Rosa-Neto, P. and Leuzy, A. . Molecular Imaging of Alzheimer’s disease using PET. The
Canadian Review of Alzheimer’s Disease and Other Dementias January 2008,18-24.
http://www.stacommunications.com/customcomm/backissue_pages/ad_review/adPDFs/2008/january2008/AD%20Review-Jan08_E.pdf
7. Goertzen, AL. Janicki, C. and Rosa-Neto, P. Dosimetry of PET tracers in mice using
microPET scans as an input functions. ©2005 MIC IEEE.
8. Palmini, A., Andermann, F., Da Costa, J. C., Rosa Neto, P. Neuronal migration disorders
and seizures in children: neurobiology, epileptic syndromes, neuroimaging, and surgical
treatment. In New Trends in Pediatric Neurology, N. Fejerman and N.A. Chamoles
(Editors), Elsevier Science Publishers, 1993.
Pubmed Peer review ed papers
*Trainees are highlighted in bold
Curriculum Vitae
21
Pedro Rosa Neto, MD. M.Sc, Ph.D.
1.
R. ZE, Parent MJ, Leuzy A, et al. Imaging in vivo glutamate fluctuations with
[(11)C]ABP688: a GLT-1 challenge with ceftriaxone. Journal of Cerebral Blood Flow
& Metabolism 2015;35:1169-74.
2.
Orban P, Madjar C, Savard M, et al. Test-retest resting-state fMRI in healthy
elderly persons with a family history of Alzheimer’s disease. Scientific data 2015;2.
3.
Leuzy A, Zimmer E, Dubois J, et al. In vivo characterization of metabotropic
glutamate receptor type 5 abnormalities in behavioral variant FTD. Brain Structure
and Function 2015:1-16.
4.
Kim D, Kim RG, Kim H-S, et al. Longitudinal changes in resting-state brain
activity in a capsular infarct model. Journal of Cerebral Blood Flow & Metabolism
2015;35:11-9.
5.
DuBois JM, Rousset OG, Rowley J, et al. Characterization of age/sex and the
regional distribution of mGluR5 availability in the healthy human brain measured
by high-resolution [C]ABP688 PET. European Journal of Nuclear Medicine and
Molecular Imaging 2015:1-11.
6.
Cyr M, Parent MJ, Mechawar N, et al. Deficit in sustained attention following
selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as
measured with both post-mortem immunocytochemistry and in vivo PET imaging
with [(1)(8)F]fluoroethoxybenzovesamicol. Behav Brain Res 2015;278:107-14.
7.
Chamoun M, Huppe-Gourgues F, Legault I, Rosa-Neto P, Faubert J, Vaucher E.
Does donepezil improve visual stimuli detection and perceptivo-cognitive
performance of heathy young adults ? Journal of Vision 2015;15:1133.
8.
Zimmer ER, Parent MJ, Cuello AC, Gauthier S, Rosa-Neto P. MicroPET imaging
and transgenic models: a blueprint for Alzheimer's disease clinical research. Trends
Neurosci 2014;37:629-41.
9.
Zimmer ER, Leuzy A, Gauthier S, Rosa-Neto P. Developments in Tau PET
Imaging. Can J Neurol Sci 2014;41:547-53.
10.
Zimmer ER, Leuzy A, Bhat V, Gauthier S, Rosa-Neto P. In vivo tracking of tau
pathology using positron emission tomography (PET) molecular imaging in small
animals. Transl Neurodegener 2014;3:6.
11.
Zimmer ER, Leuzy A, Benedet AL, Breitner J, Gauthier S, Rosa-Neto P.
Tracking neuroinflammation in Alzheimer's disease: the role of positron emission
tomography imaging. J Neuroinflammation 2014;11:120.
Curriculum Vitae
22
Pedro Rosa Neto, MD. M.Sc, Ph.D.
12.
Wu L, Soder RB, Schoemaker D, et al. Resting state executive control network
adaptations in amnestic mild cognitive impairment. J Alzheimers Dis 2014;40:9931004.
13.
Ongali B, Nicolakakis N, Tong XK, et al. Angiotensin II type 1 receptor blocker
losartan prevents and rescues cerebrovascular, neuropathological and cognitive
deficits in an Alzheimer's disease model. Neurobiol Dis 2014;68:126-36.
14.
Milella MS, Marengo L, Larcher K, et al. Limbic system mGluR5 availability in
cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study.
Neuroimage 2014;98:195-202.
15.
Leuzy A, Zimmer ER, Heurling K, Rosa-Neto P, Gauthier S. Use of amyloid PET
across the spectrum of Alzheimer's disease: clinical utility and associated ethical
issues. Amyloid 2014;21:143-8.
16.
Leuzy A, Zimmer ER, Bhat V, Rosa-Neto P, Gauthier S. Imaging biomarkers for
amyloid: a new generation of probes and what lies ahead. Int Psychogeriatr
2014;26:703-7.
17.
Kim HS, Kim D, Kim RG, et al. A rat model of photothrombotic capsular infarct
with a marked motor deficit: a behavioral, histologic, and microPET study. J Cereb
Blood Flow Metab 2014;34:683-9.
18.
Gauthier S, Leuzy A, Rosa-Neto P. How can we improve transfer of outcomes
from randomized clinical trials to clinical practice with disease-modifying drugs in
Alzheimer's disease? Neurodegener Dis 2014;13:197-9.
19.
Cyr M, Parent MJ, Mechawar N, et al. PET imaging with
[(1)(8)F]fluoroethoxybenzovesamicol ([(1)(8)F]FEOBV) following selective lesion
of cholinergic pedunculopontine tegmental neurons in rat. Nucl Med Biol
2014;41:96-101.
20.
Bernard-Gauthier V, Aliaga A, Aliaga A, et al. Synthesis and evaluation of
carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase (Trk)
inhibitors: exploration of the 4-aza-2-oxindole scaffold as Trk PET imaging agents.
ACS Chem Neurosci 2014;6:260-76.
21.
Zhao L, Boucher M, Rosa-Neto P, Evans AC. Impact of scale space search on
age- and gender-related changes in MRI-based cortical morphometry. Hum Brain
Mapp 2013;34:2113-28.
22.
Soucy JP, Bartha R, Bocti C, et al. Clinical applications of neuroimaging in
patients with Alzheimer's disease: a review from the Fourth Canadian Consensus
Conference on the Diagnosis and Treatment of Dementia 2012. Alzheimers Res Ther
2013;5:S3.
Curriculum Vitae
23
Pedro Rosa Neto, MD. M.Sc, Ph.D.
23.
Schilling LP, Kieling RR, Pascoal TA, et al. Bilateral perisylvian ulegyria: an
under-recognized, surgically remediable epileptic syndrome. Epilepsia
2013;54:1360-7.
24.
Rowley J, Fonov V, Wu O, et al. White matter abnormalities and structural
hippocampal disconnections in amnestic mild cognitive impairment and Alzheimer's
disease. PLoS One 2013;8:e74776.
25.
Rosa-Neto P, Hsiung GY, Masellis M, participants C. Fluid biomarkers for
diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and
Treatment of Dementia recommendations for Canadian physicians. Alzheimers Res
Ther 2013;5:S8.
26.
Parent MJ, Cyr M, Aliaga A, et al. Concordance between in vivo and
postmortem measurements of cholinergic denervation in rats using PET with
[18F]FEOBV and choline acetyltransferase immunochemistry. EJNMMI Res
2013;3:70.
27.
Parent MJ, Bedard MA, Aliaga A, et al. Cholinergic Depletion in Alzheimer's
Disease Shown by [ (18) F]FEOBV Autoradiography. Int J Mol Imaging
2013;2013:205045.
28.
Papadopoulos P, Rosa-Neto P, Rochford J, Hamel E. Pioglitazone improves
reversal learning and exerts mixed cerebrovascular effects in a mouse model of
Alzheimer's disease with combined amyloid-beta and cerebrovascular pathology.
PLoS One 2013;8:e68612.
29.
Kandratavicius L, Rosa-Neto P, Monteiro MR, et al. Distinct increased
metabotropic glutamate receptor type 5 (mGluR5) in temporal lobe epilepsy with
and without hippocampal sclerosis. Hippocampus 2013;23:1212-30.
30.
Gauthier S, Rosa-Neto P. Dementia: Disclosure of results to participants in
dementia research. Nat Rev Neurol 2013;9:608-9.
31.
Gauthier S, Leuzy A, Racine E, Rosa-Neto P. Diagnosis and management of
Alzheimer's disease: past, present and future ethical issues. Prog Neurobiol
2013;110:102-13.
32.
Burhan AM, Bartha R, Bocti C, et al. Role of emerging neuroimaging
modalities in patients with cognitive impairment: a review from the Canadian
Consensus Conference on the Diagnosis and Treatment of Dementia 2012.
Alzheimers Res Ther 2013;5:S4.
33.
Bernard-Gauthier V, Boudjemeline M, Rosa-Neto P, Thiel A, Schirrmacher R.
Towards tropomyosin-related kinase B (TrkB) receptor ligands for brain imaging
with PET: radiosynthesis and evaluation of 2-(4-[(18)F]fluorophenyl)-7,8Curriculum Vitae
24
Pedro Rosa Neto, MD. M.Sc, Ph.D.
dihydroxy-4H-chromen-4-one and 2-(4-([N-methyl-(11)C]-dimethylamino)phenyl)7,8-dihydroxy-4H-chromen-4-one. Bioorg Med Chem 2013;21:7816-29.
34.
Wu L, Rowley J, Mohades S, et al. Dissociation between brain amyloid
deposition and metabolism in early mild cognitive impairment. PLoS One
2012;7:e47905.
35.
Wu L, Rosa-Neto P, Hsiung GY, et al. Early-onset familial Alzheimer's disease
(EOFAD). Can J Neurol Sci 2012;39:436-45.
36.
Tong XK, Lecrux C, Rosa-Neto P, Hamel E. Age-dependent rescue by
simvastatin of Alzheimer's disease cerebrovascular and memory deficits. J Neurosci
2012;32:4705-15.
37.
Parent M, Bedard MA, Aliaga A, et al. PET imaging of cholinergic deficits in
rats using [18F]fluoroethoxybenzovesamicol ([18F]FEOBV). Neuroimage
2012;62:555-61.
38.
Kovacevic T, Skelin I, Minuzzi L, Rosa-Neto P, Diksic M. Reduced
metabotropic glutamate receptor 5 in the Flinders Sensitive Line of rats, an animal
model of depression: an autoradiographic study. Brain Res Bull 2012;87:406-12.
39.
Gauthier S, Wu L, Rosa-Neto P, Jia J. Prevention strategies for Alzheimer's
disease. Transl Neurodegener 2012;1:13.
40.
Gauthier S, Patterson C, Chertkow H, et al. 4th Canadian Consensus
Conference on the Diagnosis and Treatment of Dementia. Canadian Journal of
Neurological Sciences / Journal Canadien des Sciences Neurologiques 2012;39:S1S8.
41.
Gauthier S, Patterson C, Chertkow H, et al. Recommendations of the 4th
Canadian Consensus Conference on the Diagnosis and Treatment of Dementia
(CCCDTD4). Can Geriatr J 2012;15:120-6.
42.
Elmenhorst D, Aliaga A, Bauer A, Rosa-Neto P. Test-retest stability of cerebral
mGluR(5) quantification using [(1)(1)C]ABP688 and positron emission tomography
in rats. Synapse 2012;66:552-60.
43.
Wu L, Rosa-Neto P, Gauthier S. Use of biomarkers in clinical trials of
Alzheimer disease: from concept to application. Mol Diagn Ther 2011;15:313-25.
44.
Oishi K, Huang H, Yoshioka T, et al. Superficially located white matter
structures commonly seen in the human and the macaque brain with diffusion
tensor imaging. Brain Connect 2011;1:37-47.
Curriculum Vitae
25
Pedro Rosa Neto, MD. M.Sc, Ph.D.
45.
Nicolakakis N, Aboulkassim T, Aliaga A, Tong XK, Rosa-Neto P, Hamel E.
Intact memory in TGF-beta1 transgenic mice featuring chronic cerebrovascular
deficit: recovery with pioglitazone. J Cereb Blood Flow Metab 2011;31:200-11.
46.
Kumakura Y, Natsume J, Toussaint P, et al. Generation of Functional Images
of The Brain Trapping Constant for α-[11C] Methyl-L-Tryptophan Using Constrained
Linear Regression. Open Medical Imaging Journal 2011;5:14-25.
47.
Chen ZJ, He Y, Rosa-Neto P, Gong G, Evans AC. Age-related alterations in the
modular organization of structural cortical network by using cortical thickness from
MRI. Neuroimage 2011;56:235-45.
48.
Berney A, Leyton M, Gravel P, et al. Brain regional alpha-[11C]methyl-Ltryptophan trapping in medication-free patients with obsessive-compulsive
disorder. Arch Gen Psychiatry 2011;68:732-41.
49.
Zhang Y, Zhang J, Oishi K, et al. Atlas-guided tract reconstruction for
automated and comprehensive examination of the white matter anatomy.
Neuroimage 2010;52:1289-301.
50.
Verhaeghe J, Gravel P, Mio R, et al. Motion compensation for fully 4D PET
reconstruction using PET superset data. Phys Med Biol 2010;55:4063-82.
51.
Ongali B, Nicolakakis N, Lecrux C, et al. Transgenic mice overexpressing APP
and transforming growth factor-beta1 feature cognitive and vascular hallmarks of
Alzheimer's disease. Am J Pathol 2010;177:3071-80.
52.
la Fougere C, Boning G, Bartmann H, et al. Uptake and binding of the
serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel Pglycoprotein inhibitor tariquidar. Neuroimage 2010;49:1406-15.
53.
Elmenhorst D, Minuzzi L, Aliaga A, et al. In vivo and in vitro validation of
reference tissue models for the mGluR(5) ligand [(11)C]ABP688. J Cereb Blood Flow
Metab 2010;30:1538-49.
54.
Bertomeu T, Zvereff V, Ibrahim A, et al. TLN-4601 peripheral benzodiazepine
receptor (PBR/TSPO) binding properties do not mediate apoptosis but confer
tumor-specific accumulation. Biochem Pharmacol 2010;80:1572-9.
55.
Bellec P, Rosa-Neto P, Lyttelton OC, Benali H, Evans AC. Multi-level bootstrap
analysis of stable clusters in resting-state fMRI. Neuroimage 2010;51:1126-39.
56.
Rosa-Neto P, Wangler B, Iovkova L, et al. [18F]SiFA-isothiocyanate: a new
highly effective radioactive labeling agent for lysine-containing proteins.
Chembiochem 2009;10:1321-4.
Curriculum Vitae
26
Pedro Rosa Neto, MD. M.Sc, Ph.D.
57.
Oishi K, Faria A, Jiang H, et al. Atlas-based whole brain white matter analysis
using large deformation diffeomorphic metric mapping: application to normal
elderly and Alzheimer's disease participants. Neuroimage 2009;46:486-99.
58.
Massarweh G, Kovacevic M, Rosa-Neto P, Evans AC, Diksic M, Schirrmacher R.
Time-efficient and convenient synthesis of [(18)F]altanserin for human PET imaging
by a new work-up procedure. Appl Radiat Isot 2009;67:2040-3.
59.
Gong G, Rosa-Neto P, Carbonell F, Chen ZJ, He Y, Evans AC. Age- and genderrelated differences in the cortical anatomical network. J Neurosci 2009;29:1568493.
60.
Chakravarty MM, Rosa-Neto P, Broadbent S, Evans AC, Collins DL. Robust S1,
S2, and thalamic activations in individual subjects with vibrotactile stimulation at
1.5 and 3.0 T. Hum Brain Mapp 2009;30:1328-37.
61.
Chakravarty MM, Broadbent S, Rosa-Neto P, Lambert CM, Collins DL. Design,
construction, and validation of an MRI-compatible vibrotactile stimulator intended
for clinical use. J Neurosci Methods 2009;184:129-35.
62.
Aznavour N, Benkelfat C, Gravel P, et al. MicroPET imaging of 5-HT 1A
receptors in rat brain: a test-retest [18F]MPPF study. Eur J Nucl Med Mol Imaging
2009;36:53-62.
63.
Oishi K, Zilles K, Amunts K, et al. Human brain white matter atlas:
identification and assignment of common anatomical structures in superficial white
matter. Neuroimage 2008;43:447-57.
64.
Nicolakakis N, Aboulkassim T, Ongali B, et al. Complete rescue of
cerebrovascular function in aged Alzheimer's disease transgenic mice by
antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma
agonist. J Neurosci 2008;28:9287-96.
65.
Mori S, Oishi K, Jiang H, et al. Stereotaxic white matter atlas based on
diffusion tensor imaging in an ICBM template. Neuroimage 2008;40:570-82.
66.
Frey BN, Rosa-Neto P, Lubarsky S, Diksic M. Correlation between serotonin
synthesis and 5-HT1A receptor binding in the living human brain: a combined
alpha-[11C]MT and [18F]MPPF positron emission tomography study. Neuroimage
2008;42:850-7.
67.
Chen ZJ, He Y, Rosa-Neto P, Germann J, Evans AC. Revealing modular
architecture of human brain structural networks by using cortical thickness from
MRI. Cereb Cortex 2008;18:2374-81.
Curriculum Vitae
27
Pedro Rosa Neto, MD. M.Sc, Ph.D.
68.
Rosa-Neto P, Benkelfat C, Sakai Y, Leyton M, Morais JA, Diksic M. Brain
regional alpha-[11C]methyl-L-tryptophan trapping, used as an index of 5-HT
synthesis, in healthy adults: absence of an age effect. Eur J Nucl Med Mol Imaging
2007;34:1254-64.
69.
Pedersen K, Simonsen M, Ostergaard SD, et al. Mapping the amphetamineevoked changes in [11C]raclopride binding in living rat using small animal PET:
modulation by MAO-inhibition. Neuroimage 2007;35:38-46.
70.
Mzengeza S, Lakhrissi Y, Rosa‐Neto P, et al. Radiosynthesis of cis‐4‐
[124I] iodo‐L‐proline as a prototype probe for imaging anterograde axoplasmic
transport systems using positron emission tomography (PET). Journal of Labelled
Compounds and Radiopharmaceuticals 2007;50:636-7.
71.
Leyton M, Paquette V, Gravel P, et al. alpha-[11C]Methyl-L-tryptophan
trapping in the orbital and ventral medial prefrontal cortex of suicide attempters.
Eur Neuropsychopharmacol 2006;16:220-3.
72.
Doudet DJ, Rosa-Neto P, Munk OL, Ruth TJ, Jivan S, Cumming P. Effect of age
on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus
monkeys: a multi-tracer PET study. Neuroimage 2006;30:26-35.
73.
Rosa-Neto P, Lou HC, Cumming P, et al. Methylphenidate-evoked changes in
striatal dopamine correlate with inattention and impulsivity in adolescents with
attention deficit hyperactivity disorder. Neuroimage 2005;25:868-76.
74.
Rosa-Neto P, Diksic M, Leyton M, Mzengeza S, Benkelfat C. Stability of alpha[11C]methyl-L-tryptophan brain trapping in healthy male volunteers. Eur J Nucl
Med Mol Imaging 2005;32:1199-204.
75.
Gjedde A, Wong DF, Rosa-Neto P, Cumming P. Mapping neuroreceptors at
work: on the definition and interpretation of binding potentials after 20 years of
progress. Int Rev Neurobiol 2005;63:1-20.
76.
Rosa-Neto P, Olsen AK, Gjedde A, Watanabe H, Cumming P. MDMA-evoked
changes in cerebral blood flow in living porcine brain: correlation with
hyperthermia. Synapse 2004;53:214-21.
77.
Rosa-Neto P, Gjedde A, Olsen AK, et al. MDMA-evoked changes in
[11C]raclopride and [11C]NMSP binding in living pig brain. Synapse 2004;53:22233.
78.
Rosa-Neto P, Doudet DJ, Cumming P. Gradients of dopamine D1- and D2/3binding sites in the basal ganglia of pig and monkey measured by PET. Neuroimage
2004;22:1076-83.
Curriculum Vitae
28
Pedro Rosa Neto, MD. M.Sc, Ph.D.
79.
Rosa-Neto P, Diksic M, Okazawa H, et al. Measurement of brain regional
alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in
medication-free patients with major depression. Arch Gen Psychiatry 2004;61:55663.
80.
Lou HC, Rosa, Pedro, et al. ADHD: increased dopamine receptor availability
linked to attention deficit and low neonatal cerebral blood flow. Developmental
Medicine & Child Neurology 2004;46:179-83.
81.
Natsume J, Kumakura Y, Bernasconi N, et al. Alpha-[11C] methyl-Ltryptophan and glucose metabolism in patients with temporal lobe epilepsy.
Neurology 2003;60:756-61.
82.
Nakai A, Kumakura Y, Boivin M, et al. Sex differences of brain serotonin
synthesis in patients with irritable bowel syndrome using alpha-[11C]methyl-Ltryptophan, positron emission tomography and statistical parametric mapping. Can
J Gastroenterol 2003;17:191-6.
83.
Josephs KA, Holton JL, Rossor MN, et al. Neurofilament inclusion body
disease: a new proteinopathy? Brain 2003;126:2291-303.
84.
Cumming P, Rosa-Neto P, Watanabe H, et al. Effects of acute nicotine on
hemodynamics and binding of [11C]raclopride to dopamine D2,3 receptors in pig
brain. Neuroimage 2003;19:1127-36.
85.
Rosa Neto P, Lou H, Cumming P, Pryds O, Gjedde A. Methylphenidate-evoked
potentiation of extracellular dopamine in the brain of adolescents with premature
birth: correlation with attentional deficit. Ann N Y Acad Sci 2002;965:434-9.
86.
Leyton M, Okazawa H, Diksic M, et al. Brain Regional alpha-[11C]methyl-Ltryptophan trapping in impulsive subjects with borderline personality disorder. Am
J Psychiatry 2001;158:775-82.
87.
Bernasconi A, Martinez V, Rosa-Neto P, et al. Surgical resection for intractable
epilepsy in "double cortex" syndrome yields inadequate results. Epilepsia
2001;42:1124-9.
88.
Chae JS, Kim HI, Chung CO, et al. Surgical management of MRI-invisible
extratemporal epilepsy. Journal of Korean Neurosurgical Society 1999;28:1573-8.
89.
Lopes-Cendes I, Teive HG, Calcagnotto ME, et al. Frequency of the different
mutations causing spinocerebellar ataxia (SCA1, SCA2, MJD/SCA3 and DRPLA) in a
large group of Brazilian patients. Arq Neuropsiquiatr 1997;55:519-29.
Curriculum Vitae
29
Pedro Rosa Neto, MD. M.Sc, Ph.D.
90.
Kim H-I, Palmini A, Lee M-C, et al. Surgical strategy and management of
intractable epilepsy associated with cortical dysplasia. CHONNAM JOURNAL OF
MEDICAL SCIENCES 1997;10:179-87.
91.
Cho KK, Kim HI, Lee MC, et al. Surgical Treatment of Focal Cortical Dysplasia.
Journal of Korean Neurosurgical Society 1996;25:2418-24.
92.
Staub H, Capobianco K, Neto P, Keiserman M. Rheumatoid arthritis,
transverse myelitis and antiphospholipid antibodies. Clinical and experimental
rheumatology 1992;10:626-7.
Curriculum Vitae
30
Pedro Rosa Neto, MD. M.Sc, Ph.D.
Abstracts
*Trainees are highlighted in bold
1. Connectome-wide analysis of differences between normal aging, mild cognitive
impairment, and dementia of the alzheimer's type using resting-state fmri
connectivity, Tam, A, Orban, P, Dansereau, C, Belleville, S, Benoit, S, Dagher, A,
Joubert, S, Monchi, O, Peters, F, Rosa-Neto, P, Rouleau, I, Shmuel, A, Breitner,
JCS and Bellec, P, Journal/Alzheimers & Dementia, 2014, 10, P827-P828,
Elsevier Ltd, Alzheimer Association International Conference (AAIC), Copenhagen
July, 2014
2. Regional association maps describe dynamic architecture of amyloidosis and
hypometabolism in alzheimer's disease, Mohades, SS, Mohades, S,
Zimmer, ER, Carbonell, F, Beaudry, T, Parent, M, Benedet, AL, Wang, S, Shin,
M, Fonov, VS, Zimmer ER, L, Leuzy, A, Schilling, LP, Manitsirikul, S, Eskildsen,
S, Kang, MS, Gauthier, S and Rosa-Neto, P, Journal/Alzheimers & Dementia,
2014, 10, P108, Elsevier Ltd, Alzheimer Association International Conference
(AAIC), Copenhagen July, 2014
3. White matter abnormalities and structural parietal disconnections in
alzheimer's disease, Schilling, LP, Zimmer, ER, Leuzy, A, Benedet, AL,
Pascoal, T, Mohades, S, Mohades, S, Zimmer ER, L, Shin, M, Parent, M, Kang,
MS, Manitsirikul, S, Farajat, D, Wang, S, Di Ciero, J, Beaudry, T, Eskildsen, S,
Rowley, J, Carbonell, F, Fonov, V, Gauthier, S and Rosa-Neto, P,
Journal/Alzheimers & Dementia, 2014, 10, P835, Elsevier Ltd, Alzheimer
Association International Conference (AAIC), Copenhagen July, 2014
4. Amyloidosis changes associations between hippocampus volume and brain
metabolic declines, Kang, MS, Parent, M, Shin, M, Zimmer, ER, Aliaga, A,
Mathieu, A, Mohadesi, SS, Mohades, S, Manitsirikul, S, Soucy, J-P, Gauthier, S,
Cuello, C and Rosa-Neto, P, Journal/Alzheimers & Dementia, 2014, 10,
P413-P414, Elsevier Ltd, Alzheimer Association International Conference (AAIC),
Copenhagen July, 2014
5. In vitro properties of [18f]nav4694: Dynamic range, displacement, and white-matter
binding, Zimmer, ER, Leuzy, A, Aliaga, A, Zimmer ER, L, Mohades, S,
Schilling, LP, Benedet, AL, Schirrmacher, ES, Soucy, J-P, Guiot, M-C, Reininger,
C, Gauthier, S and Rosa-Neto, P, Journal/Alzheimers & Dementia, 2014, 10,
P23-P24, Elsevier Ltd, Alzheimer Association International Conference (AAIC),
Copenhagen July, 2014
6. Neurodegeneration associated with longitudinal changes of ab1-42 and fibrillary
amyloid, Zimmer ER, L, Manitsirikul, S, Mohades, S, Wang, S, Shin, M,
Benedet, AL, Leuzy, A, Parent, M, Zimmer, ER, Kang, MS, Schilling, LP,
Farajat, D, Fonov, V, Beaudry, T, Mohadesi, S, Gauthier, S and Rosa-Neto, P,
Journal/Alzheimers & Dementia, 2014, 10, P79-P80, Elsevier Ltd, Alzheimer
Association International Conference (AAIC), Copenhagen July, 2014
7. Longitudinal collection of cerebrospinal fluid in rats: A minimally invasive method,
Zimmer, ER, Parent, M, Leuzy, A, Shin, M, Kang, MS, Schilling, LP, Benedet,
AL, Portela, L, Dea, D, Poirier, J, Gauthier, S, Cuello, C and Rosa-Neto, P,
Journal/Alzheimers & Dementia, 2014, 10, P356, Elsevier Ltd, Alzheimer
Curriculum Vitae
31
Pedro Rosa Neto, MD. M.Sc, Ph.D.
Association International Conference (AAIC), Copenhagen July, 2014
8. Glucose metabolism impact on functional connectivity in alzheimer's
disease, Wang, S, Carbonell, F, Beaudry, T, Mohadesi, SS, Leuzy, A, Mohades,
S, Zimmer, ER, Fonov, V, Bellec, P, Gauthier, S and Rosa-Neto, P,
Journal/Alzheimers & Dementia, 2014, 10, P80, Elsevier Ltd, Alzheimer
Association International Conference (AAIC), Copenhagen July, 2014
9. Hippocampal atrophy in the mcgill-r-thy1-app rat model of alzheimer's
disease: A follow up study, Shin, M, Parent, M, Zimmer, ER, Kang, MS, Mathieu,
A, Wang, S, Allard, S, Do Carmo, S, Gauthier, S, Cuello, C and Rosa-Neto, P,
Journal/Alzheimers & Dementia, 2014, 10, P477, Elsevier Ltd, Alzheimer
Association International Conference (AAIC), Copenhagen July, 2014
10. Competitive binding of [11c]pib and [18f]nav4694 in a transgenic rat model of
amyloidosis, Parent, M, Zimmer, ER, Shin, M, Kang, M, DoCarmo, S, Aliaga, A,
Reininger, C, Soucy, J-P, Gauthier, S, Cuello, C and Rosa-Neto, P,
Journal/Alzheimers & Dementia, 2014, 10, P893, Elsevier Ltd, Alzheimer
Association International Conference (AAIC), Copenhagen July, 2014
11. Epistasis analyses indicate association between cerebral amyloid deposition and
genes involved in immunoresponse, Benedet, A, Lemay, P, Mohadesi, SS,
Mohades, S, Zimmer, ER, Dionne-Laporte, A, Picard, C, Shin, M, Wang, S,
Parent, M, Schilling, LP, Beaudry, T, Carbonnell, F, Fonov, V, Gauthier, S,
Rouleau, G, Poirier, J and Rosa-Neto, P, Journal/Alzheimers & Dementia,
2014, 10, P321, Elsevier Ltd, Alzheimer Association International Conference
(AAIC), Copenhagen July, 2014
12. Parietal white matter tract alterations in mci and alzheimer's disease
patients from the adni dataset, Beaudry, T, Lafaille-Magnan, M-E, Rowley, J,
Schilling, LP, Mohades, S, Farajat, D, Shin, M, Gauthier, S and Rosa-Neto, P,
Journal/Alzheimers & Dementia, 2014, 10, P895-P896, Elsevier Ltd,
Alzheimer Association International Conference (AAIC), Copenhagen July, 2014
13. In vitro quantification of tau pathology in alzheimer's disease: An [18f]t807
autoradiographic study, Leuzy, A, Zimmer, ER, Aliaga, A, Schilling, L, Guiot, MC, Schirrmacher, E, Soucy, J-P, Gauthier, S and Rosa-Neto, P,
Journal/Alzheimers & Dementia, 2014, 10, P116-P117, Elsevier Ltd,
Alzheimer Association International Conference (AAIC), Copenhagen July, 2014
14. Hypometabolism and cortical atrophy in [18f]florbetapir accumulators and nonaccumulators, Mohades, S, Mohadesi, SS, Parent, M, Shin, M, Wang, S,
Benedet, AL, Leuzy, A, Beaudry, T, Zimmer, ER, Zimmer ER, L, Farajat, D,
Fonov, V, Eskildsen, S, Gauthier, S and Rosa-Neto, P, Journal/Alzheimers &
Dementia, 2014, 10, P169, Elsevier Ltd, Alzheimer Association International
Conference (AAIC), Copenhagen July, 2014
15. Epistasis analyses indicate association between cerebral amyloid deposition and
genes involved in immuno-response, Benedet, A, Lemay, P, Mohades, SS,
Mohades, S, Zimmer, ER, Dionne-Laporte, A, Picard, C, Shin, M, Wang, S,
Parent, M, Schilling, LP, Carbonnell, F, Beaudry, T, Fonov, V, Gauthier, S,
Rouleau, G, Poirier, J and Rosa-Neto, P, Journal/Alzheimers & Dementia,
Curriculum Vitae
32
Pedro Rosa Neto, MD. M.Sc, Ph.D.
2014, 10, P98-P99, Elsevier Ltd, Alzheimer Association International Conference
(AAIC), Copenhagen July, 2014
16. Glucose metabolism impact on functional connectivity in alzheimer's
disease, Wang, S, Mohadesi, SS, Parent, M, Mohades, S, Leuzy, A, Zimmer,
ER, Benedet, AL, Fonov, VS, Carbonell, F, Bellec, P, Gauthier, S and Rosa-Neto,
P, Journal/Alzheimers & Dementia, 2014, 10, P840-P841, Elsevier Ltd,
Alzheimer Association International Conference (AAIC), Copenhagen July, 2014
17. Correlations between various moca cognitive domain assessments and regional
brain fdg-pet hypometabolism, Zimmer ER, L, Mohades, S, Shin, M, Mohadesi,
SS, Wang, S, Benedet, AL, Beaudry, T, Manitsirikul, S, Leuzy, A, Fonov, VS,
Schilling, LP, Rosa-Neto, P and Gauthier, S, Journal/Alzheimers &
Dementia, 2014, 10, P834, Elsevier Ltd, Alzheimer Association International
Conference (AAIC), Copenhagen July, 2014
18. Tracking neuroinflammation in alzheimer's disease: The role of positron
emission tomography imaging., Zimmer, ER, Leuzy, A, Benedet, AL, Breitner, J,
Gauthier, S and Rosa-Neto, P, Journal/Journal of Neuroinflammation, 2014, 11,
120, BioMed Central Ltd, Alzheimer Association International Conference (AAIC),
Copenhagen July, 2014
19. Longitudinal follow-up of amyloidosis and glucose hypometabolism in a transgenic
rat model of alzheimer's disease, Parent, M, Zimmer, ER, Shin, M, Kang,
MS, Do Carmo, S, Aliaga, A, Reininger, C, Soucy, J-P, Gauthier, S, Cuello, AC
and Rosa-Neto, P, Journal/Alzheimers & Dementia, 2014, 10, P28-P29,
Elsevier Ltd, Alzheimer Association International Conference (AAIC), Copenhagen
July, 2014
20. How should we assess functional performance in individuals with mild cognitive
impairment (mci)?, da Cunha Belchior, P, Kwok, JCW, Gélinas, I and Rosa-Neto,
P, Journal/Alzheimers & Dementia, 2014, 10, P692, Elsevier Ltd, Alzheimer
Association International Conference (AAIC), Copenhagen July, 2014
21. Use of amyloid pet across the spectrum of alzheimer's disease: Clinical
utility and associated ethical issues., Leuzy, A, Zimmer, ER, Heurling, K, RosaNeto, P and Gauthier, S, Journal/Amyloid-Journal of Protein Folding Disorders,
2014, 21, 143-148, Informa UK Ltd. London, Alzheimer Association International
Conference (AAIC), Copenhagen July, 2014
22. Longitudinal quantification of brain amyloidosis in a rat model of Alzheimer’s
disease using [18F]NAV4694. Maxime J. Parent (McGill Centre for Studies in
Aging), MinSu P. Kang, Sonia Do Carmo, Antonio Aliaga, Cornelia Reininger,
Jean-Paul Soucy, Serge G. Gauthier, A. Claudio Cuello, Pedro Rosa-Neto. Human
Amyloid meeting. Miami January 14-16 2014
23. Gauthier, S., Jia,J., Belleville, S., Doudet,D., Hsiung, JY., Labbe, A., Li,D., Qin,W.,
Rosa-Neto, P., Sadovnick, D., Soucy, JP., Wu L. anada-China Cohort Study of
early-onset familial Alzheimer's disease Alzheimer’s disease Alzheimer’s
Association International Conference, Boston, 13-18 July 2013
24. Lafaille-Magnan, ME., Breitner J., Etienne, P., Poirier, J., Fontaine, D., Rosa-Neto,
P., Rajah, N. Olfactory identification as a potential marker of presymptomatic
Curriculum Vitae
33
Pedro Rosa Neto, MD. M.Sc, Ph.D.
Alzheimer's disease. Alzheimer's & Dementia: The Journal of the Alzheimer's
Association Vol. 9, Issue 4, Supplement, Page P208. Alzheimer’s disease
Alzheimer’s Association International Conference, Boston, 13-18 July 2013
25. Tedeschi Dauar M, Beaudry T, Fonov V, Leuzy A, Zimmer ER L, Gauthier S,
Rosa-Neto P. Association between memory and amyloid deposition–synaptic
dysfunction in people with EMCI, LMCI and Alzheimer’s disease Alzheimer’s
Association International Conference, Boston, 13-18 July 2013
26. Shin, M. Gauthier, S. Wand, S. Parent, M. Fonov, V. Allard, S., Kang, MS, Do
Carmo, S. Cuello, C and Rosa-Neto, P. Assessment of Hippocampal Volumetry in
Transgenic AD Rat. Alzheimer’s Association International Conference, Boston, 1318 July 2013.
27. Parent M, Shin M, Do Carmo S, Aliaga A, Gauthier S, Cuello A.C, Rosa-Neto P.
Amyloid-induced fMRI Resting-state Connectivity Impairment in A Rat Model of
Alzheimer’s Alzheimer’s Association International Conference, Boston, 13-18 July
2013.
28. Mohades S, Dubois J, Parent M, Rowley J, Shin M, Zimmer ER L, Beaudry T,
Fonov V, Leuzy A, TedeschiDauar M, Gauthier S, Rosa-Neto P. Association
between Cortical thickness and CSF Biomarkers in Mild Cognitive Impairment and
AD. Alzheimer’s Association International Conference, Boston, 13-18 July 2013.
29. Zimmer ER L, Rowley J, Mohades S, Leuzy A, Beaudry T, Fonov V, Gauthier S,
Rosa-Neto P. Regional distribution of brain fibrillar amyloid deposition as a function
of CSF Aβ1-42 and biomarkers of neurodegeneration. Alzheimer’s Association
International Conference, Boston, 13-18 July 2013. Oral presentation.
30. Zimmer ER L, Rowley J., Mohades S, Leuzy A, Beaudry T, Fonov V, Gauthier S,
Rosa-Neto P. Differential impact of amyloidosis and tau pathology on brain
metabolism. poster presentation. Alzheimer’s Association International
Conference, Boston, 13-18 July 2013.
31. Leuzy A, Rowley J, Zimmer ER L, Parent M, Shin M, Wang S, Zimmer ER,
Gauthier S, Rosa-Neto P. In vivo characterization of glutamatergic vulnerability in
behavioral variant FTD and AD: an [11C]ABP-688 PET/ VBM /DBM study.
Alzheimer’s Association International Conference, Boston, 13-18 July 2013. Oral
presentation Alzheimer's Association Vol. 9, Issue 4, Supplement, Page P846
32. Leuzy A, Rowley J, Zimmer ER L, Parent M, Shin M, Wang S, Zimmer ER,
Gauthier S, Rosa-Neto P. In vivo characterization of glutamatergic vulnerability in
behavioral variant FTD: an [11C]ABP-688 PET/ VBM /DBM study. Alzheimer’s
Association Imaging Consortium. Alzheimer’s Association International
Conference, Boston, 13-18 July 2013. Oral presentation.
33. Parent M, Do Carmo S, Aliaga A, Gauthier S, Cuello A.C, Rosa-Neto, P. Amyloid
Accumulation And Neurodegeneration In A Rat Model Of Alzheimer’s Diseas E.
Human Amyloid Imaging – 14-14 Jan 2013, Miami, USA. Poster presentation
34. Zimmer ER L, Rowley J, Mohades S, Leuzy A, TedeschiDauar M, Shin M,
Wang S, Beaudry T, Fonov V, Eskildsen SF, Gauthier, S, Rosa-Neto P.
Association between amyloidosis and neurodegeneration measured by imaging
Curriculum Vitae
34
Pedro Rosa Neto, MD. M.Sc, Ph.D.
biomarkers and cerebrospinal fluid. Human Amyloid Imaging – 14-14 Jan 2013,
Miami, USA. Poster presentation
35. Leuzy A, Rowley J, Fonov V, Eskildsen SF, Shin M, Rosa-Neto P, Gauthier S.
ADNI. Increased mean diffusivity is associated with hypometabolism but not
amyloidosis in MCI and AD: a DTI / [18F]AV45 / [18F]FDG PET study. Human
Amyloid Imaging – 14-14 Jan 2013, Miami, USA. Poster presentation
36. Rowley J, Wu L, Mohades S, et al. Brain amyloid deposition and metabolism in
early and late mild cognitive impairment. Alzheimers & Dementia 2012;8:P12P13
37. Wu L, Rowley J, Mohades S, et al. Brain beta-amyloid deposition and metabolism
in early and late mild cognitive impairment. Alzheimers & Dementia
2012;8:P485-P486.
38. Leuzy A, Rowley J, Mohades S, et al. Confrontation naming deficits are
associated with amyloidosis in early MCI and with synaptic dysfunction in late MCI
and Alzheimer's disease: An [18F]AV45/[18F]FDG-PET study. Alzheimers
& Dementia 2012;8:P507-P508.
39. Dauar M, Rowley J, Wu L, et al. Association between brain amyloidosis, synaptic
dysfunction and cognitive performance measured with ADAS-cog and MMSE
scores in early MCI, late MCI and Alzheimer's disease. Alzheimers &
Dementia 2012;8:P48-P49.
40. Soucy J-P, Soder R, Rosa-Neto P, Gauthier S. Defining an optimal approach for
evaluating regional metabolism with 18F-FDG-PET imaging: Anatomical versus
probabilistic volumes of interest. Alzheimers & Dementia 2012;8:P20-P21
41. Rowley J, Wu L, Mohades S, et al. Regional patterns of amyloidosis and synaptic
dysfunction associated with auditory verbal learning: A PET study utilizing FDG
and AV45 from ADNI. Alzheimers & Dementia 2012;8:P519-P520.
42. Parent M., Bedard M; Aliaga A, Mechawar N; Soucy JP. Rosa-Neto P.
Quantification of Cholinergic Degeneration in Alzheimer’s Disease using
[18F]Fluoroethoxy benzovesamicol Neuroreceptor Meeting, August 10-17 Aug.
Baltimore, USA
43. Wu, L. Rowey, J.; Mohades, S.; Shin, M. Gauthier, S. Rosa-Neto, P.
Comparison Between Anatomically and Probabilistically-Driven Volumes of
Interests for Quantifying Amyloidosis in Prodromal AD. Human Amyloid Imaging
12-13 January 2012, Miami Beach Resort
44. Dauar M, Wu L, Rowley J, et al. Association between brain amyloidosis, synaptic
dysfunction and cognitive performance measured with ADAS-cog and MMSE
scores in EMCI, LMCI and Alzheimer's disease. Alzheimers &
Dementia 2012;8:P524
45. Parent M, Bedard M-A, Rosa-Neto P, et al. Reliability and sensitivity to detect
cortical cholinergic denervation in rats using PET imaging with
[18F]Fluoroethoxybenzovesamicol. Alzheimers & Dementia 2011;7:S34.
Curriculum Vitae
35
Pedro Rosa Neto, MD. M.Sc, Ph.D.
46. Rosa-Neto P, Gauthier S, Soucy J-P, et al. PET and tissue autoradiography
evidence of decline of metabotropic glutamate receptor type 5 (mGluR5) in the
prefrontal cortex of Alzheimer's disease. Alzheimers & Dementia
2011;7:S111 ORAL PRESENTATION
47. Rosa-Neto P., Rowley J., Van Noorth B., Shoemaker, D. Minuzzi, L., Soucy JP., Kandratavicious, L Reader A., Gravel, P., Fonov, V., Verhaeghe J., and
Gauthier, S. Declines of Metabotropic Glutamate Receptor in Patients with Early
AD: In Vivo Evidence of a Novel Biomarker for Hippocampal Dysfunction.
American Academy of Neurology Meeting, Toronto, April 2010. Oral Presentation,
Meeting Highlights
48. Minuzzi, L., Diksic, M., Gauthier,S., Quirion, R., Rosa-Neto, P. . Declines of
Hippocampal Metabotropic Glutamate Metabotropic Gluramate Receptors Type 5
in Alzheimer's Disease. ICAD 09- Intrenational Conference on Quantification of
brain function with PET. Vienna
49. Kobayashi, E., Hall, J., Guiot, M.-C., Andermann, F., Dubeau, F., Diksic, M.,
Massarweh, G., Soucy, J-P., Rosa-Neto, P.. Abnormal [11C]ABP688 binding in
patients with temporal lobe epilepsy.Brain09- Intrenational Conference on
Quantification of brain function with PET., June29-July04, 2009.
50. Elmenhorst, D., Biagini M., Minuzzi, L., Aliaga, A., Massarweh, G., Diksic, M.,
Avoli , M., Bauer A.,Rosa-Neto P. Evaluation of reference models for [11C]ABP688
targeting the metabotropic glutamate receptor type 5 in rats- application in a
epilepsy model. Brain09- Intrenational Conference on Quantification of brain
function with PET., June29-July04, 2009. Oral Presentation.
51. Minuzzi, L., Diksic, M., Gauthier, S., Quirion, R., Rosa-Neto, P. In vitro
quantification of mGLUR5 in pons and cerebelum of the human brain using
[3H]ABP688. Brain09- Intrenational Conference on Quantification of brain function
with PET. June29-July04, 2009.
52. Minuzzi, L., Kobayashi, E.,. Hall, J.,Guiot,M.-C., Andermann, F., Dubeau, F.,
Diksic, M, Massarweh, G., Soucy, J-P., Rosa-Neto, P., Reduction of mGLUR5
binding sites in hippocampi from patients with pharmaco-resistant temporal lobe
epilepsy: an autoradiography study, Brain09- Intrenational Conference on
Quantification of brain function with PET. Chicago, June29-July04, 2009.
53. Thiel A, Rosa-Neto, P., Schirrmacher, E, Schipper, H., and Schirrmacher, R.
Carbamylated erythropoietin (I-125-CEPO) as potential radiotracer for imaging
neuroprotection in cerebral ischemia
54. Rowley, J., Kobayashi, E., Hall, Andermann, F., Dubeau, F., Diksic, M.,
Massarweh, G., Rosa-Neto P.. A comparison of linear and nonlinear methods for
registration of PET images. Brain09- Intrenational Conference on Quantification of
brain function with PET., June29-July04, 2009.
55. Landry St-Pierre, E.; Rosa-Neto, P,; Massarweh, G.; , Alliaga, A.; Mengeza, S.; ,
Bédard, MA.; Soucy, JP. Plasma chromatographic profile of [18F]-FEOBV in rat:
results and implications for clinical applications
56. Frey, B.N.; Rosa-Neto, P.; Lubarsky, S.; and Diksic, M.; Correlation between
Curriculum Vitae
36
Pedro Rosa Neto, MD. M.Sc, Ph.D.
serotonin synthesis and 5HT1A receptor binding: a combined α-[11C]MT and
[18F]MPPF imaging study
57. Landry St-Pierre, E.; Rosa-Neto, P,; Massarweh, G.; , Alliaga, A.; Mengeza, S.; ,
Bédard, MA.; Soucy, JP. Plasma chromatographic profile of [18F]-FEOBV in rat:
results and implications for clinical applications
58. Landry St-Pierre, E.; Rosa-Neto, P,; Massarweh, G.; , Alliaga, A.; Mengeza, S.; ,
Bédard, MA.; Soucy, JP. Distribution of [18F]-FEOBV in rat: a promising tracer for
imaging cholinergic innervation densities.
59. Rosa-Neto P., He Y., Chen ZJ., Evans, AC. Small world properties of the 5-HT2A
receptor network of the human brain. Human Brain Mapping. Chicago 2007
60. Chen, ZJ., He, Y., Rosa-Neto, P., Germann J. ,Evans, AC. Regional Thickness
Covariance in the Human Cortex. Human Brain Mapping. Chicago 2007.
61. Rosa-Neto P., Chakravarty M., Collins L, Evans A.C. Ipsilateral suppression of the
sensory thalamo-cortical circuit during unilateral vibrotactile hand stimulation.
Human Brain Mapping. Chicago 2007.
62. He Y., Chen ZJ, Rosa-Neto P, Jurgen Germann, Alan Evans Small-World Human
Brain Volumetric Network Revealed by Structural MRI. Human Brain Mapping.
Chicago 2007.
63. Lou HC., Rosa-Neto P., Skewes J., Kjaer, T., Gjedde A.. Dopaminergic regulation
of conscious experience. 23rd International Symposium on Cerebral Blood Flow,
Metabolism & Function (Brain’07) Osaka, May 2007.
64. Mzengeza S., Massarweh, G., Rosa-Neto, P., Soucy, Jean-Paul, Bedard, MA.
Radiosynthesis of [18F]FEOBV and in vivo pet imaging of acetylcholine vesicular
transporter in the rat. International Conference on Quantification of Brain Function
with PET (BrainPET’07). Osaka, May 2007.
65. Rosa-Neto P., Alliaga A., Mzengeza S., Massarweh G. Landry E., Bedard, MA.,
Soucy J-P. Imaging vesicular acetylcholine transporter in rodents using
[18f]fluoroethoxy-benzovesamicol and micropet. International Conference on
Quantification of Brain Function with PET (BrainPET’07). Osaka, May 2007.
66. Rosa-Neto P., Alliaga A., Goertzen AL. S., Massarweh G. Landry E., Bedard, MA.,
Soucy J-P. (+/-)fenfluramine and (+/-)mdma are equipotent serotonin releasers in
limbic and non-limbic areas: an micropet [18F]MPPF study. International
Conference on Quantification of Brain Function with PET (BrainPET’07). Osaka,
May 2007.
67. Aliaga A., Rosa-Neto, P., Mzengeza S., Del Maestro, RF , Evans AC,Bedell BJ.
MicroPET Studies of PK11195 Binding to the Peripheral Benzodiazepine Receptor
in Rodent Glioma Models. International Conference on Quantification of Brain
Function with PET (BrainPET’07). Osaka, May 2007.
68. Goertzen, A.L., Rosa-Neto, P. and Thompson, C.J., "Accelerated microPET
transmission scanning." Presented at the 53rd Annual Meeting of the Society of
Curriculum Vitae
37
Pedro Rosa Neto, MD. M.Sc, Ph.D.
Nuclear Medicine, San Diego, CA 3-7 June 2006.
69. Rosa-Neto, P., Goertzen, A.L., Aliaga, A,, Soucy, JP., and Evans, A.C. .
Activation of the visual system in awake rats using [18F]FDG. Human Brain
Mapping meeting. Florence. Italy.
70. Goertzen, A.L., Janicki, C. and Rosa-Neto, P., "Dosimetry of PET tracers in mice
using microPET scans as an input function." Presented at the IEEE NSS-MIC, San
Juan, Puerto Rico, 23-29 October 2005.
71. Rosa-Neto, P., Goertzen, A.L., Diksic, M., Mzengeza, S., Dagher, A., Soucy, JP.,
Sadikot, A., and Evans, A.C. Dopamine D2/3 receptor binding in aphakia mice
measured by microPET. Brain PET 2005. Amsterdam.
72. Rosa-Neto, P., Goertzen, A.L., Diksic, M., Mzengeza, S., Dagher, A., Soucy, JP.,
Sadikot, A., and Evans, A.C. Receptor binding and glucose metabolism in aphakia
mice measured by microPET: preliminary results with [11C]raclopride and
[18F]FDG. Abstract submitted to Human Brain Mapping meeting. Toronto
73. Wallentin, M., Lung Ellegaard, T., Ostergaard, S., Rosa-Neto, P., Ostergaard, L.,
Roespstorff, A. It makes sense! Meaningful sentences activate the reward circuit
in the brain.
74. Goertzen, A.L., Rosa-Neto, P., Diksic, M., Mzengeza, S., Dagher, A., Soucy, JP.,
Sadikot, A., and Evans, A.C. Effect of reconstruction algorithm choice in C-11
raclopride DVR measurements of the mouse striatum using the microPET R4.
Abstract submitted to the annual meeting of Society for Nuclear Medicine 2005.
Amsterdam.
75. Rosa-Neto, P.; Lind, N. ; Olsen, A.K.; Gjedde, A.; Cumming, P.. MDMA evokes
greater declines of [11C]raclopride binding potentials in the dorsal striatum that
does d-amphetamine. Society for Neurosciences, San Diego, November 2004.
76. Wu, O. Christensen, S. N,. Hjort, Rosa-Neto, P., Rodell, A.,Dijkhuizen, R. M. ,
Fiehler, J. Röther, J., Østergaard, L. Can multiparametric MRI-based predictive
algorithms assess efficacy of thrombolysis in hyperacute stroke patients? ISMRM
workshop in Venice, March, 2004.
77. Wu, O. Christensen, S. Rosa-Neto, P., N. Hjort, Rodell, A.,Dijkhuizen, R. M. ,
Fiehler, J. Röther, J., Østergaard, L. Anatomy as a parameter in multiparametic
MRI-based predictive algorithms. ISMRM workshop in Venice, March, 2004.
78. Cumming P., Rosa-Neto P., Munk O.L., Doudet D. Presynaptic markers for
monoaminergic innervations in a monkey model of Parkinson’s disease.
Scandinavian Congress of Physiology and Pharmacology, Odense, Denmark,
October 11-14, 2003.
79. Rosa-Neto, P., OlsenK. A , Jensen SB., Munk OL, Watanabe H., Gjedde A., and
Cumming P. Segregation of dopamine D1 and D2-like binding sites in basal
ganglia in monkey and pig: a PET study [Oral Presentation]. BRAIN –PET 2003,
Calgary, Alberta, Canada.
80. Rosa-Neto, P., OlsenK. A , Jensen SB., Munk OL, Watanabe H., Gjedde A., and
Curriculum Vitae
38
Pedro Rosa Neto, MD. M.Sc, Ph.D.
Cumming P. MDMA-evoked competition between [11C]raclopride and endogenous
dopamine. BRAIN –PET 2003, Calgary, Alberta, Canada.
81. Gjedde, A., Wong, D.F., Rosa-Neto, P., and Cumming, P. (2002) Reference region
hyperplots of brain uptake of FDOPA and [11C]raclopride. Neuroreceptor
Mapping, Oxford, July 19-21, 2002.
82. Rosa-Neto, P., Lou, H.C., Cumming, P., and Gjedde, A. (2002) Dopamine release
correlates with inattention and impulsivity in ADHD. Neuroreceptor Mapping,
Oxford, July 19-21, 2002.
83. Rosa-Neto, P., Cumming, P., Munk, O.L., and Gjedde, A. (2002) Rostro-caudal
distribution of D1 and D2 dopamine receptors in striatum mapped with [11C]NNC112 and [11C]raclopride. Neuroreceptor Mapping, Oxford, July 19-21, 2002.
84. Rosa-Neto, P., Diksic, M., Okazawa, H., Mzengeza, S., Leyton, M., Kumakura, Y.,
Nakai, A., Morais, J., Benkelfat, C. Plasma-to-brain clearance of alpha[11C]methyltryptophan in healthy volunteers: No Age Effect. American College for
Neuropsychopharmacology, SanJuan, Puerto Rico 10-14 December 2000.
85. Benkelfat, C., Leyton, M., Rosa-Neto, P., Nakai, A., Debonnel, G., Sookman, D.,
Paris, J., Diksic, M. alpha-[11C]-methyltryptophan brain uptake and trapping in
frontal circuits in medication-free patients with impulse-control disorders. American
College for Neuropsychopharmacology, San Juan, Puerto Rico, December 2000.
86. Natsume, J., Fedi, M., Rosa-Neto, P., Bernasconi, A., Bernasconi, N., Nakai, A.,
Kumakura, Y., Dubeau, F., Andermann, F., Lisbona, R., Diksic, M. Temporal
uptake of alpha-[11C]methyl-L-Tryptophan in patients with intractable temporal
lobe epilepsy: evaluation with Positron Emission Tomography. Annual Meeting of
the American Epilepsy Society, December 2000, Los Angeles, CA. Epilepsia 41
(suppl.7) p. 58.
87. Rosa-Neto, P., Andermann, F., Natsume, J., Lisbona, R., Okasawa, H., Dubeau,
F., Kumakura, Y., Diksic, M. PET studies using amino acid tracers: a multimodal
analysis. Annual Meeting of the American Epilepsy Society, December 2000, Los
Angeles, CA. Epilepsia 41 (suppl.7) pp. 58-59
88. Rosa-Neto, P., Benkelfat, C., Debonnel, G. Blier, P., Diksic, M. Paroxetine-induced
local modifications of brain serotonin synthesis in depressive patients as measured
with 11C-alpha methyl-L-tryptophan and Positron Emission Tomography. 47th
Annual Meeting of the Society of Nuclear Medicine [Oral Presentation], 2000,
St.Louis, MO. JNM, 41(5), May 2000 p136p.
89. Rosa-Neto, P., Benkelfat C., Okazawa, H., Leyton, M., Mzengeza, S., Blier, P.,
Debonnel, G., Diksic, M. Regional 5-HT synthesis in patients with major
depression. Annual meeting of Society for Neurosciences, 1999.[Oral
Presentation], Miami.
90. Rosa-Neto, P., Benkelfat, C., Okazawa, H., Leyton, M., Mzengeza, S., Blier, P.,
Debonnel, G., Diksic, M. Regional rates of brain 5-HT synthesis in patients with
current major depression. Meeting of the American College of
Psychopharmacology, 1998, Porto Rico.
Curriculum Vitae
39
Pedro Rosa Neto, MD. M.Sc, Ph.D.
91. Rosa-Neto, P., Netto, C.A. Temporal evolution of the activity of glycogen
phosphorylase in rat hippocampus submitted to lethal and sub-lethal global
ischaemia. Brazilian Federation of Biological Societies. 1998, Brazil.
92. Rosa-Neto, P., Netto C.A. Temporal evolution of the activity of cytochrome
oxydase in rat hippocampus submitted to lethal and sub-lethal global ischaemia.
Brazilian Federation of Biological Societies, 1998, Brazil.
93. Kim, H.-I., Lee, M.C., Chung, C.-O., Rosa-Neto, P. MRI negative cortical
dysplasias in temporal lobe epilepsy: Pathological findings and surgical results.
Epilepsia, 38, suppl.8, 1997.
94. Kim, H-I., Palmini, A., da Costa, J.C., Rosa-Neto, P., Chung, C.-H., Choi, Y., Kim,
J., Lee, E., Paglioli-Neto, E., Paglioli, E., Calcagnotto, M.E.. Resective surgery in
selected patients with bilateral or diffuse dysplastic lesions. Epilepsia, 37,suppl. 5,
1996.
95. Chung, C.-O.; Kim, H.-I; Rosa-Neto, P., Choi, H.Y. MRI-negative extratemporal
epilepsy: pathology and surgical results. Epilepsia, 37,supl. 5, 1996.
96. Rosa-Neto, P., Ferrão, Y.A., Palmini, A., Netto, C.A., Busnello, E.D. et al. Major
depression in a patient with MELAS Syndrome. X World Congress of Psychiatry,
Madrid, Spain, 1996.
97. Rosa-Neto, P., Ferrão, Y.A., Juruena, M.F., Busnello, E.D. Sertraline in the
approach of the residual aggressiveness and impulsiveness in patients with
different neuropsychiatry diseases. I Latin-American Congress of
Neuropsychopharmacology, Salvador, Bahia, Brazil, 1995.
98. Rosa-Neto, P., Ferrão, Y.A., Juruena, M.F., Busnello, E.D. Depression in a patient
with Wilson’s disease. I Latin-American Congress of Neuropsychopharmacology,
Salvador, Bahia, Brazil, 1995.
99. Rosa-Neto, P., Ferrão,Y.A., Palmini, A., Juruena, M.F., Busnello, E.D. Maniac
Syndrome associated with frontal lobe lesions: 6 different clinical presentations”. I
Latin-American Congress of Neuropsychopharmacology, Salvador, Bahia, Brazil,
1995.
100. Rosa-Neto, P., Palmini, A., Ferrão,Y.A., Busnello,E.D. Regional abnormalities
of the cerebral blood flow in children and adults with attention deficit disorder and
hyperactivity. Dysfunction of fronto-striatal circuits. I Latin-American Congress of
Neuropsychopharmacology, Salvador, Bahia, Brazil, 1995.
101. Rosa-Neto, P., Ferrão, Y.A., Palmini, A., Juruena, M.F., Busnello, E.D. Major
depression with psychotic symptoms in patients with MELAS syndrome. I LatinAmerican Congress of Neuropsychopharmacology, Salvador, Bahia, Brazil, 1995.
102. Palmini, A, Costa, J.C., Rosa-Neto, P. et al. Startle Epilepsy Associated with
Double Cortex Syndrome. Epilepsia, 33, suppl.5, 1992.
103. Palmini, A, Costa, J.C., Rosa-Neto, P. et al. Focal Electrographic Ictal Activity
During Acute Cortical Recording Over Dysplastic Lesions in Man. Epilepsia, 33,
Curriculum Vitae
40
Pedro Rosa Neto, MD. M.Sc, Ph.D.
suppl.5, 1992.
104. Rosa-Neto, P., Garcia, L.F., Costa, J.C. Epilepsy and Moebious syndrome in
childhood: a causal association. VI Congress of the International Child Neurology
Association [Oral presentation], Buenos Aires, Argentina, 1992.
105. Palmini, A., Rosa-Neto, P. Relationship between schizophreniform symptoms
and structural lesions in temporal lobe epilepsy. XII Brazilian Congress of
Psychiatry, Gramado, Brazil, 1992.
106. Rosa-Neto, P., Garcia, L.F., Staub, H. Lupic anticoagulant as a risk factor for
cerebrovascular disorders in young patients. XV Brazilian Congress of Neurology,
Porto Alegre, Brazil, 1992.
107. Rosa-Neto, P., Ehlers, J.A., Staub, H., Islabao, A. Relapsing polychondritis
with peripheral manifestation. XV Brazilian Congress of Neurology, Porto Alegre,
Brazil, 1992.
108. Costa, J.C., Palmini, A., Rosa-Neto, P. et al. Cortical dysplasias as a cause of
epileptic seizures in childhood. XVII Meeting of Brazilian League Against Epilepsy,
Gramado, Brazil, 1992.
109. Costa J.C., Palmini, A., Rosa-Neto, P. et al. Cortical dysplasia as a cause of
status epilepticus in newborn. XVII Meeting of Brazilian League Against Epilepsy,
Gramado, Brazil, 1992.
110. Palmini, A., Costa J.C., Rosa-Neto, P. et al. Startle epilepsy associated with
double cortex syndrome. XVII Meeting of Brazilian League Against Epilepsy,
Gramado, Brazil, 1992.
111. Palmini, A., Costa, J.C., Rosa-Neto, P. et al. Fear as a seizure manifestation in
childhood: six patients study. XVII Meeting of Brazilian League Against Epilepsy,
Gramado, Brazil, 1992.
112. Palmini, A., Costa, J.C., Rosa-Neto, P. et al. Electrographic Seizures,
contralateral interictal discharges to an epileptogenic zone associated to a slow
grown tumor. XVII Meeting of Brazilian League Against Epilepsy, Gramado, Brazil,
1992.
Curriculum Vitae
41